CoChat

Enhanced T-Cell Responses to Glioma Cells Coated With the Anti-EGF Receptor Antibody and Targeted to Activating FcγRs on Human Dendritic Cells

The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.

Abstract

The induction of effective immune responses to tumor vaccines requires the preferential activation of effector T cells relative to regulatory or suppressive T cells. Glial tumors commonly overexpress the epidermal growth factor receptor (EGFR), which can be targeted by monoclonal antibodies. Here we show that the coating of glial tumor cells with a clinical grade anti-EGFR antibody, cetuximab, leads to enhanced tumor-specific, interferon-gamma producing CD8+ T cells by dendritic cells (DCs). The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus. Importantly, this approach reduces the concurrent induction of regulatory T cells, which can also be depleted to further enhance immunity. These data suggest that immunity to EGFR expressing tumors, including glioma, can be enhanced through the concerted function of antitumor monoclonal antibodies, activating FcgammaR, and DCs.

Overview

Integrity signals

Registry

Crossref · 10.1097/cji.0b013e31815a5892

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Cited by

See all 31

Metadata

Authors
Banerjee, D., Matthews, P., Matayeva, E., Kaufman, J. L., Steinman, R. M., & Dhodapkar, K. M.
Affiliations
Rockefeller University (US)
Venue
Journal of Immunotherapy
Published
2008-02
Volume
31
Issue
2
Pages
113-120
ISSN
1524-9557 (ISSN-L)
OpenAlex
W2039061028
Cited by
31
References
31
Citations by year
2022: 2 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 2
FWCI
1.67
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Immunotherapy (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (2m01rr000102-41)
  • National Institute of Allergy and Infectious Diseases (K08AI054375, P01-AI51573, AI054375, P01AI051573)
  • National Center for Research Resources (M0-1 RR00102)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
Keywords
glioma, epidermal growth factor receptor, cetuximab, anti-EGFR monoclonal antibody, dendritic cells, CD8+ T cells, interferon-gamma, regulatory T cells, tumor-specific immunity, cancer vaccines, monoclonal antibody therapy, antitumor immunity
MeSH terms
Cetuximab, Antibodies, Monoclonal, Antineoplastic Agents, Cell Differentiation, Dendritic Cells, Glioma, Humans, Interferon-gamma, Lymphocyte Activation, Cytokines, Receptors, IgG, Antigen Presentation, CD8-Positive T-Lymphocytes, Coculture Techniques, Chemokines, Cell Line, Tumor, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit, Antibodies, Monoclonal, Humanized, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhanced T-Cell Responses to Glioma Cells Coated With the Anti-EGF Receptor Antibody and Targeted to Activating FcγRs on Human Dendritic Cells. https://app.cochat.ai/papers/10.1097/cji.0b013e31815a5892
The paper
Banerjee, D., Matthews, P., Matayeva, E., Kaufman, J. L., Steinman, R. M., & Dhodapkar, K. M. (2008). Enhanced T-Cell Responses to Glioma Cells Coated With the Anti-EGF Receptor Antibody and Targeted to Activating FcγRs on Human Dendritic Cells. Journal of Immunotherapy. https://doi.org/10.1097/cji.0b013e31815a5892

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.